Treatment of <i>Candida glabrata</i> Infection in Immunosuppressed Mice by Using a Combination of Liposomal Amphotericin B with Caspofungin or Micafungin
ABSTRACT While Candida albicans remains the most common Candida isolate, Candida glabrata accounts for approximately 15 to 20% of all Candida infections in the United States. In this study we used immunosuppressed mice infected with C. glabrata to investigate the efficacy of liposomal amphotericin B...
Gorde:
Egile Nagusiak: | Jon Olson, Jill Adler‐Moore, Peter J. Smith, Richard T. Proffitt |
---|---|
Formatua: | Artigo |
Hizkuntza: | ingelesa |
Argitaratua: |
2005
|
Sarrera elektronikoa: | https://doi.org/10.1128/aac.49.12.4895-4902.2005 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Antzeko izenburuak
-
Treatment of Candida glabrata Infection in Immunosuppressed Mice by Using a Combination of Liposomal Amphotericin B with Caspofungin or Micafungin
nork: Olson, Jon A., et al.
Argitaratua: (2005) -
Caspofungin in Combination with Amphotericin B against Candida glabrata
nork: Barchiesi, Francesco, et al.
Argitaratua: (2005) -
Killing Kinetics of Caspofungin, Micafungin, and Amphotericin B against Candida guilliermondii
nork: Cantón, Emilia, et al.
Argitaratua: (2006) -
Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report
nork: Yamada, Shoko Merrit, et al.
Argitaratua: (2016) -
Candida glabrata Mutants Demonstrating Paradoxical Reduced Caspofungin Susceptibility but Increased Micafungin Susceptibility
nork: Healey, Kelley R., et al.
Argitaratua: (2011)